| Thu, Jul 9, 2009 | | | Human Genome Sciences' anthrax drug works in tests AP (Thu 5:05pm)
| | | RothmanResearch.com Stock Review for IVN, MAT, DVN, LBTYA, HGSI and CTXS Marketwire (Thu 8:18am)
| | | Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of Inhalation Anthrax PR Newswire (Thu 7:00am)
| | Wed, Jul 8, 2009 | | | UPDATE - Drug helps monkeys, rabbits survive anthrax -study at Reuters (Wed, Jul 8)
| | Tue, Jul 7, 2009 | | | A Wager On More Weakness In Retail at Forbes.com (Tue, Jul 7)
| | | Tuesday Options Update: AIG, DFS, GE, PBR & HGSI at Seeking Alpha (Tue, Jul 7)
| | Wed, Jul 1, 2009 | | | [$$] Still Moving Sideways at RealMoney by TheStreet.com (Wed, Jul 1)
| | Sun, Jun 28, 2009 | | | FDA Extreme Trades: 16 Stocks Under 5 Bucks at Seeking Alpha (Sun, Jun 28)
| | Tue, Jun 23, 2009 | | | Don't Miss This Cheap Stock at Motley Fool (Tue, Jun 23)
| | Mon, Jun 22, 2009 | | | 5 Stocks Bucking the Downtrend at Motley Fool (Mon, Jun 22)
| | Fri, Jun 19, 2009 | | | Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Piper Jaffray Conference PR Newswire (Fri, Jun 19)
| | | Human Genome Sciences Announces Completion of Enrollment in Phase 2b Monthly-Dosing Trial of Albuferon(R) PR Newswire (Fri, Jun 19)
| | Fri, Jun 12, 2009 | | | Movers roundup: Ezcorp, Skilled Healthcare AP (Fri, Jun 12)
| | | Where Good Drugs Go to Die at Motley Fool (Fri, Jun 12)
| | | Human Genome shares fall on Lazard analyst outlook AP (Fri, Jun 12)
| | | Healthcare Stocks: Favorable Reaction to Treasury Markets at Seeking Alpha (Fri, Jun 12)
| | | UPDATE - Lazard cuts Human Genome to sell at Reuters (Fri, Jun 12)
| | | Human Genome downgraded by Lazard Capital Mkts Briefing.com (Fri, Jun 12)
| | | FDA Calendar Updates: BDSI, SVNT Deadlines Approach at Seeking Alpha (Fri, Jun 12)
| | | [$$] Stone Rolls Onward; Big 5 Has a Bad Day at The Wall Street Journal Online (Fri, Jun 12)
| Add HGSI News to My Yahoo!:

| |
|